Basic Information
Ikerian is a Swiss company that develops software solutions to accelerate global clinical, research, and pharmaceutical workflows using advanced machine learning and computer vision. RetinaAI builds tools for collecting, organizing, and analyzing eye health data, enabling healthcare professionals to make the right decisions faster in medical care. RetinaAI's international team leverages its clinical, technical, and scientific expertise to facilitate the shift from reactive medicine to preventive medicine for serious eye diseases. RetinaAI collaborates with ophthalmology experts to help expedite data analysis and more effectively achieve goal-based research to improve research design and clinical studies. RetinaAI's data management platform and models, including artificial intelligence models for geographic atrophy progression prediction, can analyze large-scale datasets to gain insights into biomarker profiles and patient subgroups or outcomes.
Ikerian AG
Bern(Berne),Berne,Switzerland
15~50 people
December 16, 2016
info@retinai.com

